Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants

• Váldodahkkit: Nicola P. Klein (Dahkki), Remon Abu-Elyazeed (Dahkki), Yaela Baine (Dahkki), Brigitte Cheuvart (Dahkki), Marcela Silerova (Dahkki), Narcisa Mesaros (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2019-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

This phase III, open-label, randomized study (NCT01978093) evaluated the immunogenicity and safety of co-administered Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (Hib-MenCY-TT) with human rotavirus vaccine (HRV), hepatitis A vaccine (HAV)...